Vernalis acquires US rights to Moxatag
2 October 2015 | By Victoria White
Moxatag is a penicillin-class antibacterial indicated for the treatment of tonsillitis and pharyngitis secondary to streptococcus pyogenes...
List view / Grid view
2 October 2015 | By Victoria White
Moxatag is a penicillin-class antibacterial indicated for the treatment of tonsillitis and pharyngitis secondary to streptococcus pyogenes...
8 September 2015 | By Victoria White
Tuzistra XR is the only codeine-based extended-release cough cold syrup available to patients and physicians in the United States...
20 August 2015 | By Victoria White
Vernalis has announced results from a Phase II proof-of-concept study of V158866, its fatty acid amide hydrolase (FAAH) inhibitor...